These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 27862098)

  • 41. Statins Inhibit Toll-Like Receptor 4-Mediated Growth of Human Esophageal Adenocarcinoma Cells.
    Gergen AK; Kohtz PD; Halpern AL; White AM; Meng X; Fullerton DA; Weyant MJ
    J Surg Res; 2021 Apr; 260():436-447. PubMed ID: 33272595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
    Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
    Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simvastatin delays castration‑resistant prostate cancer metastasis and androgen receptor antagonist resistance by regulating the expression of caveolin‑1.
    Gao Y; Li L; Li T; Ma L; Yuan M; Sun W; Cheng HL; Niu L; Du Z; Quan Z; Fan Y; Fan J; Luo C; Wu X
    Int J Oncol; 2019 Jun; 54(6):2054-2068. PubMed ID: 31081050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
    Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q
    Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prostatic environment suppresses growth of androgen-independent prostate cancer xenografts: an effect influenced by testosterone.
    Jennbacken K; Gustavsson H; Tesan T; Horn M; Vallbo C; Welén K; Damber JE
    Prostate; 2009 Aug; 69(11):1164-75. PubMed ID: 19399749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Annexin A10 Expression as a Novel Prognostic Marker in Lung Adenocarcinoma.
    Yumura M; Nagano T; Jimbo N; Dokuni R; Kiriu T; Tanaka Y; Tachihara M; Itoh T; Maniwa Y; Nishimura Y; Kobayashi K
    Anticancer Res; 2022 Mar; 42(3):1289-1294. PubMed ID: 35220218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of simvastatin on castration-resistant prostate cancer cells.
    Kim JH; Cox ME; Wasan KM
    Lipids Health Dis; 2014 Mar; 13():56. PubMed ID: 24666612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adrenomedullin blockade suppresses growth of human hormone-independent prostate tumor xenograft in mice.
    Berenguer-Daizé C; Boudouresque F; Bastide C; Tounsi A; Benyahia Z; Acunzo J; Dussault N; Delfino C; Baeza N; Daniel L; Cayol M; Rossi D; El Battari A; Bertin D; Mabrouk K; Martin PM; Ouafik L
    Clin Cancer Res; 2013 Nov; 19(22):6138-50. PubMed ID: 24100627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical, Cellular, and Molecular Evidence of the Additive Antitumor Effects of Biguanides and Statins in Prostate Cancer.
    Jiménez-Vacas JM; Herrero-Aguayo V; Montero-Hidalgo AJ; Sáez-Martínez P; Gómez-Gómez E; León-González AJ; Fuentes-Fayos AC; Yubero-Serrano EM; Requena-Tapia MJ; López M; Castaño JP; Gahete MD; Luque RM
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e696-e710. PubMed ID: 33247590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells.
    Nakane K; Fujita Y; Terazawa R; Atsumi Y; Kato T; Nozawa Y; Deguchi T; Ito M
    Int J Urol; 2012 Jan; 19(1):71-9. PubMed ID: 22050448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
    Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
    Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human antigen R is positively associated with malignant aggressiveness via upregulation of cell proliferation, migration, and vascular endothelial growth factors and cyclooxygenase-2 in prostate cancer.
    Mitsunari K; Miyata Y; Asai A; Matsuo T; Shida Y; Hakariya T; Sakai H
    Transl Res; 2016 Sep; 175():116-28. PubMed ID: 27140699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
    Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
    Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PRKAR2B promotes prostate cancer metastasis by activating Wnt/β-catenin and inducing epithelial-mesenchymal transition.
    Sha J; Han Q; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Xue W
    J Cell Biochem; 2018 Sep; 119(9):7319-7327. PubMed ID: 29761841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination of carmustine and selenite effectively inhibits tumor growth by targeting androgen receptor, androgen receptor-variants, and Akt in preclinical models: New hope for patients with castration resistant prostate cancer.
    Thamilselvan V; Menon M; Thamilselvan S
    Int J Cancer; 2016 Oct; 139(7):1632-47. PubMed ID: 27198552
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dihydrotestosterone enhances castration-resistant prostate cancer cell proliferation through STAT5 activation via glucocorticoid receptor pathway.
    Song C; Kim Y; Min GE; Ahn H
    Prostate; 2014 Sep; 74(12):1240-8. PubMed ID: 25043756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy.
    Zeng X; Hu Z; Wang Z; Tao J; Lu T; Yang C; Lee B; Ye Z
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):119-25. PubMed ID: 24418912
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
    Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.